Cannabinoid CB1 receptor agonists increase rat cortical and hippocampal acetylcholine release in vivo

European Journal of Pharmacology

Volumn 401, Issue 2, 2000, Pages 179-185

  Acquas, Elio ^a   Pisanu, Augusta ^a   Marrocu, Paola ^a   Di Chiara, Gaetano ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Acetylcholine; Cortex, prefrontal; Hippocampus; HU 210; Microdialysis; SR 141716A; WIN 55, 212 2

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; ACETYLCHOLINE; CANNABINOID RECEPTOR AGONIST; DEXANABINOL; RIMONABANT;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; COGNITION; CONTROLLED STUDY; HIPPOCAMPUS; IN VIVO STUDY; MALE; MICRODIALYSIS; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SMOKING;

ACETYLCHOLINE; ANIMALS; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HIPPOCAMPUS; MALE; MICRODIALYSIS; MORPHOLINES; NAPHTHALENES; PIPERIDINES; PREFRONTAL CORTEX; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; TETRAHYDROCANNABINOL;

EID: 0034604754     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00403-9     Document Type: Article

References (24)

1. Acquas E., Wilson C., Fibiger H.C. Conditioned and unconditioned stimuli increase frontal cortical and hippocampal acetylcholine release: effects of novelty, habituation and fear. J. Neurosci. 16(9):1996;3089-3096.
2. Acquas E., Wilson C., Fibiger H.C. Pharmacology of sensory stimulation-evoked increases in frontal cortical acetylcholine release. Neuroscience. 85(1):1998;73-83.
3. Bouaboula M., Perrachon S., Milligan L., Canat X., Rinaldi-Carmona M., Portier M., Barth F., Calandra B., Pecceu F., Lupker J., Maffrand J.P., Le Fur G., Casellas P. A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor: 1. Evidence for a new model of receptor/ligand interactions. Biol. Chem. 272(35):1997;22330-22339.
4. Bartus R.T., Dean R.L., Pontecorvo M.J., Flicker C. The cholinergic hypothesis: a historical overview, current perspective, and future directions. Ann. N.Y. Acad. Sci. 444:1985;332-358.
5. Blokland A. Acetylcholine: a neurotransmitter for learning and memory? Brain Res. Rev. 21:1999;285-300.
6. 9-tetrahydrocannabinol in rats. Brain Res. 809:1998;1-4.
7. Casamenti F., Deffenu G., Abbamondi A.L., Pepeu G. Changes in cortical acetylcholine output induced by modulation of the nucleus basalis. Brain Res. Bull. 16:1985;689-695.
8. 14C]-deoxyglucose method for use in freely moving rats. Brain Res. 499:1988;87-92.
9. Damsma G., Westerink B.H.C., De Vries J.B., Van der Berg C.J., Hoern A.S. Measurement of acetylcholine release in freely moving rats by means of automated intracerebral dialysis. J. Neurochem. 48:1987;1523-1528.
10. Fibiger H.C. Cholinergic mechanisms in learning, memory and dementia: review of recent evidence. TiNS. 14:1991;220-223.
11. Gessa G.L., Casu M.A., Carta G., Mascia M.S. Cannabinoids decrease acetylcholine in the medial-prefrontal and hippocampus, reversal by SR 141716A. Eur. J. Pharmacol. 355:1998;119-124.
12. 1 receptors. Eur. J. Pharmacol. 341:1998;39-44.
13. Gifford A.N., Ashby C.R. Jr. Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist SR 141716A. J. Pharmacol. Exp. Ther. 277(3):1996;1431-1436.
14. Inglis F.M., Fibiger H.C. Increases in hippocampal and frontal cortical acetylcholine release associated with presentation of sensory stimuli. Neuroscience. 66:1995;81-86.
15. 9-tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism. Psychopharmacol. 126:1996;125-131.
16. Moore H., Fadel J., Sarter M., Bruno J.P. Role of accumbens and cortical dopamine receptors in the regulation of cortical acetylcholine release. Neuroscience. 88(3):1999;811-822.
17. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 2nd edn. 1986;Academic Press, Australia.
18. 9-tetrahydrocannabinol, scopolamine, and MK-801. Behav. Brain Res. 99:1999;27-34.
19. Rinaldi-Carmona M., Heaulme M., Shire D., Calandra B., Congy C., Martinez S., Maruani J., Nèliat G., Caput D., Ferrara P., Soubriè P., Brélière J.-C., Le Fur G. SR 141716A a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350:1994;240-252.
20. Robbins T.W., Everitt B.J. Arousal systems and attention. Cazzaniga M The Cognitive Neurosciences. 1994;703-720 MIT Press, Cambridge, MA.
21. Sarter M., Bruno J.P. Trans-synaptic stimulation of cortical acetylcholine and enhancement of attentional functions: a rational approach for the development of cognition enhancers. Behav. Brain Res. 83:1997;7-14.
22. Schwaber J.S., Rogers W.T., Satoh K., Fibiger H.C. Distribution and organization of cholinergic neurons in the rat forebrain by computer-aided data acquisition and three-dimensional reconstruction. J. Comp. Neurol. 263:1987;309-325.
23. Solowij N., Michie P.T., Fox A.M. Effects of long-term cannabis use on selective attention: an event-related potential study. Pharmacol. Biochem. Behav. 40:1991;683-688.
24. 1 opioid receptor mechanism. Science. 276:1997;2048-2050.